News Qingdao Vland Biotech INC.

Equities

603739

CNE100003GX8

End-of-day quote Shanghai S.E. Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
11.46 ^CNY	+9.98%		+18.14%	-24.70%

Apr. 25	Qingdao Vland Biotech INC. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 25	Qingdao Vland Biotech INC. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Qingdao Vland Biotech INC. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Qingdao Vland Biotech INC. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 25	CI
Qingdao Vland Biotech INC. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-27	CI
Qingdao Vland Biotech Forms Chinese JV With Germany’s Evonik	23-10-13	MT
Qingdao Vland Biotech INC. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
Qingdao Vland Biotech INC. completed the acquisition of 51% stake in Qingdao RBT Biotechnology Co., Ltd. from Qingdao Jurun Management Consulting Partnership (Limited Partnership), Qingdao Gerunpu Management Consulting Partnership (Limited Partnership) and other individual shareholders.	23-08-15	CI
Qingdao Vland Biotech Acquires 51% of Runbot Biotechnology for 91.8 Million Yuan	23-07-21	MT
Qingdao Vland Biotech INC. signed a share transfer agreement to acquire a 51% stake in Qingdao RBT Biotechnology Co., Ltd. from Qingdao Jurun Management Consulting Partnership (Limited Partnership), Qingdao Gerunpu Management Consulting Partnership (Limited Partnership) and other individual shareholders for CNY 91.8 million.	23-07-20	CI
Qingdao Vland Biotech INC. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
Qingdao Vland Biotech INC. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
Qingdao Vland Biotech's Joint Venture to Invest Up to 400 Million Yuan for Probiotic Food Plant	23-03-24	MT
Qingdao Vland Biotech INC. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-28	CI
Qingdao Vland Biotech INC. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-23	CI
Qingdao Vland Biotech INC. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-19	CI
Qingdao Vland Biotech INC. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-19	CI
Qingdao Vland Biotech INC. Reports Earnings Results for the Nine Months Ended September 30, 2021	21-10-28	CI
Weifang Weizhilan Biological Technology Co., Ltd. announced that it expects to receive CNY 182.888 million in funding from Qingdao Vland Biotech INC., Archer Daniels Midland Singapore Pte Ltd.	21-10-18	CI
Archer Daniels Midland : to Create Human Probiotics Joint Venture With Qingdao Vland Biotech Group	21-10-18	MT
Qingdao Vland Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-16	CI
Qingdao Vland Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-04-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Qingdao Vland Biotech INC.

Equities

603739

CNE100003GX8

Summary

Filters